Medical laser procedures occupy a regulatory grey zone in the United States. Unlike surgical procedures that are unambiguously within the practice of medicine, laser treatments for skin conditions — including tattoo removal — are governed by a patchwork of state statutes and medical board rules that vary significantly in their requirements for who may perform them and under what level of physician oversight. 2025 has seen the most significant wave of proposed state-level regulatory activity in this space in nearly a decade.
The Current Regulatory Landscape
Tattoo removal using medical-grade lasers is classified as a procedure requiring some level of medical authorization in all fifty states, but "some level" spans an enormous range. At one end, states like California and New York require that laser procedures be performed by or under the direct supervision of a licensed physician, nurse practitioner, or physician assistant — meaning a qualified medical professional must either operate the device or be physically present in the facility during treatment.
At the other end, several states allow laser tattoo removal by trained technicians operating under a general medical director arrangement, where a physician reviews protocols and is theoretically available for consultation but may not be present at the facility during treatments. Some states have minimal formal requirements and rely primarily on FDA device regulations and general consumer protection law to govern the space.
This variation has significant practical implications. Franchise chains and medspa operators often structure their business models around states with more permissive supervision requirements, while consumer advocates and medical boards in stricter states argue that the proliferation of technician-operated removal is associated with higher rates of adverse outcomes.
New Legislation in 2025
Three states enacted new laser practice regulations in 2025. One state tightened its general supervision standard to require that a licensed nurse practitioner or physician assistant review each new patient's skin assessment before treatment commences, rather than allowing self-assessment by the technician. A second state added explicit training hour requirements for laser technicians that exceed what most national certification programs require. A third state moved laser tattoo removal from its general cosmetic laser category into a medical procedure category requiring on-site physician presence — a change significant enough to affect the operating model of several franchise chains operating in the state.
Several other states have active legislation in committee. Industry groups representing franchise chains and medspa operators have been actively lobbying against the more restrictive proposals, arguing that well-trained technicians under general supervision provide safe, effective care and that over-regulation will reduce consumer access and drive up prices without meaningful safety benefits. Medical boards have generally supported tightening, citing complaint data about adverse outcomes in technician-only settings.
The Adverse Outcome Data
Systematic data on adverse outcomes in tattoo removal is difficult to obtain because there is no central reporting requirement for non-surgical cosmetic procedure complications. What exists comes primarily from medical board complaint records, dermatologist referral patterns, and published case series of adverse outcomes treated in clinical settings.
The adverse outcomes that appear most commonly in this literature include post-inflammatory hyperpigmentation, hypopigmentation, and superficial scarring — all of which can be minimized with appropriate device settings and patient assessment but which occur at higher rates when practitioners lack sufficient training to recognize risk factors like darker Fitzpatrick skin types or recent sun exposure.
Proponents of stricter regulation argue these outcomes are preventable with proper oversight. Industry representatives counter that the overall adverse event rate in well-run franchise settings is low and that correlation between supervision levels and outcomes is not clearly established in the published data.